PCM
ALIM

Prelude Capital Management’s Alimera Sciences ALIM Stock Holding History

Prelude Capital Management’s Portfolio ALIM Stock Details ALIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-18,036
Closed -$164K – 2091
2021
Q2 		$164K Buy
18,036
+760
+4% +$7.47K ﹤0.01% 1407
2021
Q1 		$166K Buy
+17,276
New +$142K ﹤0.01% 1363
2020
Q1 		– Sell
-54
Closed – – 2151
2019
Q4 		$0 Sell
54
-6
-10% -$36 ﹤0.01% 2332
2019
Q3 		$1K Sell
60
-8
-12% -$73 ﹤0.01% 1651
2019
Q2 		$1K Sell
68
-2
-3% -$28 ﹤0.01% 1596
2019
Q1 		$1K Sell
70
-9
-11% -$137 ﹤0.01% 1712
2018
Q4 		$1K Sell
79
-1
-1% -$15 ﹤0.01% 1723
2018
Q3 		$1K Buy
80
+7
+10% +$107 ﹤0.01% 1689
2018
Q2 		$1K Sell
73
-45
-38% -$633 ﹤0.01% 1612
2018
Q1 		$2K Buy
118
+20
+20% +$355 ﹤0.01% 1453
2017
Q4 		$2K Sell
98
-1
-1% -$20 ﹤0.01% 1302
2017
Q3 		$2K Sell
99
-25
-20% -$535 ﹤0.01% 1558
2017
Q2 		$3K Buy
124
+4
+3% +$86 ﹤0.01% 1509
2017
Q1 		$3K Sell
120
-167
-58% -$3.22K ﹤0.01% 1443
2016
Q4 		$5K Sell
287
-213
-43% -$3.9K ﹤0.01% 1439
2016
Q3 		$11K Buy
+500
New +$11.5K ﹤0.01% 1421

Other funds holding ALIM

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
CCPM
Cooper Creek Partners Management New York $2.92B AUM 30.49% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return

Prelude Capital Management's ALIM Position: Q3 2021 in Review

Prelude Capital Management sold out of Alimera Sciences (ALIM) in Q3 2021, closing a stake of 18,036 shares — an estimated $164K sold.

Prelude Capital Management first reported a position in ALIM in Q3 2016 and held it in 16 quarters. The position peaked at $166K in Q1 2021. 27 funds tracked by Wall St. Rank hold ALIM as of Q3 2021.

  • Prelude Capital Management reported no remaining Alimera Sciences position as of Q3 2021 after selling out during the quarter.
  • Prelude Capital Management sold 18,036 Alimera Sciences shares in Q3 2021, an estimated $164K.
  • Prelude Capital Management first reported a position in Alimera Sciences in Q3 2016 and held it in 16 quarters.
  • Prelude Capital Management's Alimera Sciences position peaked at $166K in Q1 2021.
  • 27 funds tracked by Wall St. Rank held Alimera Sciences as of Q3 2021.

Based on Prelude Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.